T. Wiersma
Impact in
-
- Breast Cancer Treatment Studies
-
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
-
- Breast Cancer Treatment Studies 15
- Oncology 13
- Cancer Treatment and Pharmacology 6
- HER2/EGFR in Cancer Research 5
- Co-authors
- Gabe S. Sonke (12 shared papers)Erik van Werkhoven (10 shared papers)Frederieke van Duijnhoven (8 shared papers)Marie-Jeanne T. F. D. Vrancken Peeters (7 shared papers)Marieke E. M. van der Noordaa (5 shared papers)Claudette E. Loo (6 shared papers)Koen Van de Vijver (4 shared papers)Hugo M. Horlings (4 shared papers)
- Journals
- Radiotherapy and Oncology (3 papers)Annals of Surgical Oncology (3 papers)Cancer Research (3 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
T. Wiersma
23 papers receiving 281 citations
Peers
Comparison fields: 5 of 29
- Cancer Research 150
- Oncology 143
- Radiation 42
- Pathology and Forensic Medicine 81
- Radiology, Nuclear Medicine and Imaging 76
Countries citing papers authored by T. Wiersma
This map shows the geographic impact of T. Wiersma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Wiersma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Wiersma more than expected).
Fields of papers citing papers by T. Wiersma
This network shows the impact of papers produced by T. Wiersma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Wiersma. The network helps show where T. Wiersma may publish in the future.
Co-authors
The 25 scholars most cited alongside T. Wiersma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 51 | |
| 2 | 2018 | 34 | |
| 3 | 2020 | 22 | |
| 4 | 2018 | 22 | |
| 5 | 2017 | 21 | |
| 6 | 2020 | 19 | |
| 7 | 2021 | 18 | |
| 8 | 2013 | 16 | |
| 9 | 2021 | 15 | |
| 10 | 2019 | 15 | |
| 11 | 2014 | 15 | |
| 12 | 2020 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2022 | 4 | |
| 15 | 2017 | 4 | |
| 16 | 2023 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2014 | 2 | |
| 19 | 2018 | 2 | |
| 20 | 2020 | 2 |
About T. Wiersma
T. Wiersma is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 25 papers that have together received 288 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (6 papers), Breast Lesions and Carcinomas (6 papers), Medical Imaging Techniques and Applications (5 papers), Lung Cancer Treatments and Mutations (5 papers), HER2/EGFR in Cancer Research (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Advanced Breast Cancer Therapies (4 papers). The work is most often cited by research in Cancer Research (150 citations), Oncology (143 citations), Radiation (42 citations), Pathology and Forensic Medicine (81 citations) and Radiology, Nuclear Medicine and Imaging (76 citations). T. Wiersma has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Gabe S. Sonke, Erik van Werkhoven, Frederieke van Duijnhoven, Marie-Jeanne T. F. D. Vrancken Peeters, Marieke E. M. van der Noordaa, Claudette E. Loo, Koen Van de Vijver, Hugo M. Horlings, Tomas Janssen and Tessa G. Steenbruggen. Their work appears in journals such as Radiotherapy and Oncology, Annals of Surgical Oncology, Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.